Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
作者信息
Keshavjee Salmaan, Amanullah Farhana, Cattamanchi Adithya, Chaisson Richard, Dobos Karen M, Fox Gregory J, Gendelman Howard E, Gordon Richard, Hesseling Anneke, Le Van Hoi, Kampmann Beate, Kana Bavesh, Khuller Gopal, Lewinsohn David M, Lewinsohn Deborah A, Lin Philiana Ling, Lu Lenette Lin, Maartens Gary, Owen Andrew, Protopopova Marina, Rengarajan Jyothi, Rubin Eric, Salgame Padmini, Schurr Erwin, Seddon James A, Swindells Susan, Tobin David M, Udwadia Zarir, Walzl Gerhard, Srinivasan Sudha, Rustomjee Roxana, Nahid Payam
机构信息
1 Harvard Medical School, Boston, Massachusetts.
2 Harvard Medical School Center for Global Health Delivery-Dubai, Dubai, United Arab Emirates.
出版信息
Am J Respir Crit Care Med. 2019 Mar 1;199(5):564-571. doi: 10.1164/rccm.201806-1053PP.
Abstract
摘要
相似文献
1
Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection.
Am J Respir Crit Care Med. 2019 Mar 1;199(5):564-571. doi: 10.1164/rccm.201806-1053PP.
2
Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination.
Public Health Rep. 2020 Jul/Aug;135(1_suppl):38S-43S. doi: 10.1177/0033354920912710.
3
Predicting progression to active tuberculosis: A rate-limiting step on the path to elimination.
PLoS Med. 2019 May 24;16(5):e1002814. doi: 10.1371/journal.pmed.1002814. eCollection 2019 May.
4
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination.
Eur Respir J. 2013 Sep;42(3):785-801. doi: 10.1183/09031936.00205512. Epub 2013 Feb 8.
5
[Specific features of tuberculosis in childhood].
Rev Mal Respir. 2011 Apr;28(4):529-41. doi: 10.1016/j.rmr.2010.10.038. Epub 2011 Apr 1.
6
Tuberculosis Elimination, Research, and Respect for Persons.
Am J Respir Crit Care Med. 2019 Mar 1;199(5):560-563. doi: 10.1164/rccm.201809-1623ED.
7
Diagnosis and treatment of latent infection with Mycobacterium tuberculosis.
Respirology. 2013 Feb;18(2):205-16. doi: 10.1111/resp.12002.
8
[Contact tracing and prophylaxis of tuberculosis].
Ugeskr Laeger. 2011 Mar 21;173(12):883-6.
9
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions.
PLoS Med. 2016 Mar 2;13(3):e1001965. doi: 10.1371/journal.pmed.1001965. eCollection 2016 Mar.
10
Tuberculosis elimination, patients' lives and rational use of new drugs: revisited.
Eur Respir J. 2016 Feb;47(2):664-7. doi: 10.1183/13993003.01297-2015. Epub 2015 Nov 5.
引用本文的文献
1
Bayesian accuracy estimates for diagnostic tests to detect tuberculosis in captive sun bears (Helarctos malayanus) and Asiatic black bears (Ursus thibetanus) in Cambodia and Vietnam.
PLoS One. 2024 Nov 13;19(11):e0313007. doi: 10.1371/journal.pone.0313007. eCollection 2024.
2
Persistently high plasma procalcitonin levels despite successful treatment of tuberculous pleuritis and tuberculous lymphadenitis patients.
Sci Rep. 2024 Sep 29;14(1):22590. doi: 10.1038/s41598-024-71627-5.
3
Predictors for False-Negative Interferon-Gamma Release Assay Results in Hemodialysis Patients with Latent Tuberculosis Infection.
Diagnostics (Basel). 2022 Dec 28;13(1):88. doi: 10.3390/diagnostics13010088.
4
Uncovering the Mast Cell Response to .
Front Immunol. 2022 Jun 2;13:886044. doi: 10.3389/fimmu.2022.886044. eCollection 2022.
5
Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa.
BMC Infect Dis. 2022 Apr 15;22(1):381. doi: 10.1186/s12879-022-07349-8.
6
Lymphocyte-Related Immunological Indicators for Stratifying Infection.
Front Immunol. 2021 Jun 30;12:658843. doi: 10.3389/fimmu.2021.658843. eCollection 2021.
7
Lymphocyte Non-Specific Function Detection Facilitating the Stratification of Infection.
Front Immunol. 2021 Apr 19;12:641378. doi: 10.3389/fimmu.2021.641378. eCollection 2021.
8
Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR.
Front Immunol. 2021 Mar 16;11:612564. doi: 10.3389/fimmu.2020.612564. eCollection 2020.
9
New Diagnostics to Infer Risk in Tuberculosis: Is the Term "Latent Tuberculosis Infection" Obsolete?
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1460-1461. doi: 10.1164/rccm.202101-0131ED.
10
Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru.
BMC Public Health. 2021 Jan 11;21(1):121. doi: 10.1186/s12889-020-10098-5.
本文引用的文献
1
Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.
N Engl J Med. 2018 Aug 2;379(5):440-453. doi: 10.1056/NEJMoa1714283.
2
Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.
Int J Tuberc Lung Dis. 2018 Aug 1;22(8):937-944. doi: 10.5588/ijtld.17.0515.
3
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.
PLoS Pathog. 2018 Apr 9;14(4):e1006987. doi: 10.1371/journal.ppat.1006987. eCollection 2018 Apr.
4
Four-Gene Pan-African Blood Signature Predicts Progression to Tuberculosis.
Am J Respir Crit Care Med. 2018 May 1;197(9):1198-1208. doi: 10.1164/rccm.201711-2340OC.
5
High-resolution definition of humoral immune response correlates of effective immunity against HIV.
Mol Syst Biol. 2018 Mar 26;14(3):e7881. doi: 10.15252/msb.20177881.
6
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies.
Lancet Infect Dis. 2018 Jul;18(7):e183-e198. doi: 10.1016/S1473-3099(18)30110-5. Epub 2018 Mar 23.
7
Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 Antibodies.
Cancer Cell. 2018 Apr 9;33(4):664-675.e4. doi: 10.1016/j.ccell.2018.02.009. Epub 2018 Mar 22.
8
Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.
Int J Tuberc Lung Dis. 2018 Feb 1;22(2):125-132. doi: 10.5588/ijtld.17.0486.
9
Genome-wide transcriptional profiling identifies potential signatures in discriminating active tuberculosis from latent infection.
Oncotarget. 2017 Dec 4;8(68):112907-112916. doi: 10.18632/oncotarget.22889. eCollection 2017 Dec 22.
10
Prospective Discrimination of Controllers From Progressors Early After Low-Dose Mycobacterium tuberculosis Infection of Cynomolgus Macaques using Blood RNA Signatures.
J Infect Dis. 2018 Mar 28;217(8):1318-1322. doi: 10.1093/infdis/jiy006.
Zotero 插件